Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,544 | -12,248 | -39,407 | -27,025 | -15,848 |
| Depreciation Amortization | 964 | 500 | 1,724 | 1,181 | 714 |
| Income taxes - deferred | N/A | N/A | 3,842 | N/A | N/A |
| Accounts receivable | 476 | -2,143 | -476 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,684 | 720 | 30 | -1,178 | -271 |
| Other Working Capital | -2,417 | -16,797 | -25,589 | -18,804 | -13,422 |
| Other Operating Activity | 1,726 | 2,928 | 3,476 | 3,043 | 1,024 |
| Operating Cash Flow | $-28,111 | $-27,040 | $-56,400 | $-42,783 | $-27,803 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -99 | -13 | -1,294 | -1,075 | -976 |
| Purchase Of Investment | -126,338 | -34,812 | -146,049 | -119,498 | -23,195 |
| Sale Of Investment | 95,501 | 22,560 | 60,126 | 53,766 | 38,086 |
| Investing Cash Flow | $-30,936 | $-12,265 | $-87,217 | $-66,807 | $13,915 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 95,734 | N/A | 113,517 | 124,304 | 72 |
| Other Financing Activity | 0 | 582 | 10,363 | 0 | 0 |
| Financing Cash Flow | $95,734 | $582 | $123,880 | $124,304 | $72 |
| Beginning Cash Position | 71,560 | 71,560 | 91,297 | 91,297 | 91,297 |
| End Cash Position | 108,247 | 32,837 | 71,560 | 106,011 | 77,481 |
| Net Cash Flow | $36,687 | $-38,723 | $-19,737 | $14,714 | $-13,816 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,111 | -27,040 | -56,400 | -42,783 | -27,803 |
| Capital Expenditure | -99 | -13 | -1,294 | -1,075 | -976 |
| Free Cash Flow | -28,210 | -27,053 | -57,694 | -43,858 | -28,779 |